Printer Friendly

FDA issues warning on stolen medicines.

MANILA -- The Food and Drug Administration (FDA) has advised the public to be vigilant about stolen products reported by pharmaceutical company Abbott Laboratories Philippines.

Among the products reported as part of the cargo theft include Ascorbic Acid (Cecon) 500 mg chewable tablet, with registration number DRHR1608, lot numbers 44783XP, 44784XP and 44785XP and has an expiry date of Aug, 25, 2016; Mutivitamins + Iron (IberetFolic 500) filmcoated tablet, with registration number DRXY33496, lot number 44757XP and will expire on Aug. 15, 2016; and Divalproex Sodium (Epival) 250 mg enteric coated tablet, with registration number DRXY34509, lot number 44762XP and expiry date of Aug. 21, 2016.

The FDA said the lot numbers mentioned above are not guaranteed to be stored according to good storage practice (GSP).

"Thus, the safety, efficacy and quality of these lots are also not assured. These present safety risk and potential adverse health consequences," the FDA said.

It advised consumers not to purchase nor use the drug products with the stated lot numbers and report to authorities if any of these products are offered for sale.

The FDA also ordered all of its field food and drug regulation officers to seize these products if found available in the market.

"Any adverse reaction experienced from use of the aforementioned products should be reported immediately," said lawyer Nicolas Lutero III, FDA officer in charge, in a statement.

COPYRIGHT 2015 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Philippines Daily Inquirer (Makati City, Philippines)
Date:Jan 3, 2015
Previous Article:Although fewer, firecracker victims still rise to 593.
Next Article:Firework-related injuries climb to 730, says DOH.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters